https://www.selleckchem.com/pr....oducts/marimastat.ht
[This corrects the article DOI 10.3389/fonc.2021.638311.]. Endocrine therapy is administered to hormone-positive breast cancer patients to prevent distant metastasis. It is important to evaluate the risk of recurrence and to determine which patients are viable candidates for such treatment because hormone therapy has side effects that can include postmenopausal symptoms. The Clinical Treatment Score post-five years (CTS5), a simple tool for identifying candidates for endocrine therapy, was recently introduced; however, CTS5 only has
Like
Comment
Share
